Bridging the gap between academic IP and technology commercialization.


KensaGroup creates, launches and develops leading edge intellectual property platforms into successful technology-based businesses. KensaGroup uses a proprietary approach to identify and evaluate promising discoveries from universities and corporate research initiatives, then creates the necessary scientific, institutional, and financial bridges that lead from initial discovery to successful commercialization.

Latest News

01.07.20 - GNS Healthcare announces strategic investment from Merck Global Health Investment Fund...more

11.22.19 - Novomer Announces Appointment of Jeff Uhrig As Chief Executive Officer...more

07.09.19 - Cigna, Celgene join $23M funding round for AI-powered GNS Healthcare...more

07.02.19 - Discovery of New Clinical Predictors of Overall Survival in Metastatic Colorectal Cancer at ESMO 2019 in Collaboration with the Alliance for Clinical Trials in Oncology...more

05.09.19 - New Grainful flavors launching at Target...more


KensaGroup, LLC

2415 N. Triphammer Road

Ithaca, NY 14850

phone: 1.607.330.2307

Fax: 1.607.257.1139